BNP Paribas Financial Markets’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.62M | Buy |
|
|||||
|
2025
Q2 | $937K | Buy |
|
|||||
|
2025
Q1 | $627K | Sell |
|
|||||
|
2024
Q4 | $3.27M | Sell |
|
|||||
|
2024
Q3 | $4.13M | Sell |
|
|||||
|
2024
Q2 | $7.36M | Sell |
|
|||||
|
2024
Q1 | $10.2M | Buy |
|
|||||
|
2023
Q4 | $2.65M | Sell |
|
|||||
|
2023
Q3 | $5.88M | Buy |
|
|||||
|
2023
Q2 | $2.97M | Buy |
|
|||||
|
2023
Q1 | $2.16M | Sell |
|
|||||
|
2022
Q4 | $3.67M | Buy |
|
|||||
|
2022
Q3 | $3.99M | Buy |
|
|||||
|
2022
Q2 | $332K | Sell |
|
|||||
|
2022
Q1 | $1.37M | Sell |
|
|||||
|
2021
Q4 | $1.93M | Buy |
|
|||||
|
2021
Q3 | $131K | Buy |
|
|||||
|
2021
Q2 | $188K | Buy |
|
|||||
|
2021
Q1 | $72K | Sell |
|
|||||
|
2020
Q4 | $2.24M | Buy |
|
|||||
|
2020
Q3 | $597K | Buy |
|
|||||
|
2020
Q2 | $465K | Sell |
|
|||||
|
2020
Q1 | $1.63M | Buy |
|
|||||
|
2019
Q4 | $73.4K | Sell |
|
|||||
|
2019
Q3 | $1.02M | Buy |
|
|||||
|
2019
Q2 | $41K | Buy |
|